BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 22/04/2026

FDA Classifies Digital Therapy Device for Amblyopia into Class II

The FDA has classified the digital therapy device for amblyopia into Class II, a move aimed at ensuring the device's safety and effectiveness while reducing regulatory burdens and enhancing patient access.

Source: Federal Register — Food and Drug AdministrationOpen original release →